Breast cancer therapy offers hope for patients at risk of recurrence Novartis UK announced the Medicines and Healthcare ...

Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

Algiax Pharmaceuticals, a company committed to developing innovative treatments for chronic neuropathic pain, has released ...

Helsinki-based Aplagon has raised EUR 7 million to advance its APAC therapeutic for thrombo-inflammatory diseases into phase ...

SC amivantamab, in combination with LAZCLUZE, is recommended for adult patients with advanced NSCLC with epidermal growth ...

Distributing reliable information about medicines is challenging for the pharma industry and the healthcare professionals ...

UK research regulatory bodies – the Health Research Authority (HRA) and the Medicines and Healthcare products Regulatory Agency (MHRA) – are developing a set of questions and supporting guidance that ...

Imperative for AI-powered productivity enhancement ...

Yet only 5% have an approved therapy, and none offers a cure, leaving a significant unmet medical need. Due to the limited ...

Digital design can streamline pharma regulatory approval ...